Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Brief ReportBrief Communication
Open Access

The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control

Xiaojing Shang, Chunqing Song, Xiaoming Du, Hailin Shao, Donghong Xu and Xiaolai Wang
Saudi Medical Journal February 2017, 38 (2) 204-208; DOI: https://doi.org/10.15537/smj.2017.2.15649
Xiaojing Shang
From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Chunqing Song
From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoming Du
From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hailin Shao
From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donghong Xu
From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaolai Wang
From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 38 no. 2 204-208
DOI 
https://doi.org/10.15537/smj.2017.2.15649
PubMed 
28133696

Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Received July 24, 2016
  • Accepted October 26, 2016
  • Published online February 1, 2017.

Copyright & Usage 
Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

  1. Xiaojing Shang, PhD⇑,
  2. Chunqing Song, MD,
  3. Xiaoming Du, PhD,
  4. Hailin Shao, MD,
  5. Donghong Xu, MD and
  6. Xiaolai Wang, PhD
  1. From the Department of Endocrinology, Tianjin Fourth Central Hospital, and Fourth Center Clinical College, Tianjin Medical University, Tianjin, China
  1. Address correspondence and re-prints request to: Dr. Xiaojing Shang, Department of Endocrinology, Tianjin Fourth Central Hospital, Tianjin, China. E-mail: shangxiao6776{at}sina.com ORCID: http://orcid.org/0000-0002-9733-2874
View Full Text

Cited By...

  • 33 Citations
  • 31 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Metastatic pancreatic cancer: Mechanisms and detection (Review)
    Xiangling Chen, Fangfang Liu, Qingping Xue, Xiechuan Weng, Fan Xu
    Oncology Reports 2021 46 5
  • HbA1c showed a positive association with carcinoembryonic antigen (CEA) level in only diabetes, not prediabetic or normal individuals
    Soie Chung, Yunhwan Lee, Eun Youn Roh
    Journal of Clinical Laboratory Analysis 2019 33 6
  • Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A
    Yiran Zhang, Meng Zhang, Xueshan Bai, Changgui Li, Lijuan Zhang
    2019 162
  • Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma
    Hironori Kawamoto, Hiromichi Hara, Jun Araya, Akihiro Ichikawa, Yu Fujita, Hirofumi Utsumi, Mitsuo Hashimoto, Hiroshi Wakui, Shunsuke Minagawa, Takanori Numata, Seiji Arihiro, Tomokazu Matsuura, Mutsunori Fujiwara, Satoru Ito, Kazuyoshi Kuwano
    Cancers 2019 11 6
  • Survival and Glycemic Control in Patients With Colorectal Cancer and Diabetes Mellitus
    Nina J Karlin, Shailja B Amin, Heidi E Kosiorek, Matthew R Buras, Patricia M Verona, Curtiss B Cook
    Future Science OA 2018 4 9
  • HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study
    Jun Lu, Hongtao Wang, Xueli Zhang, Xuemei Yu
    Diabetes Therapy 2018 9 1
  • Serum CA72-4 is specifically elevated in gout patients and predicts flares
    Xueshan Bai, Mingshu Sun, Yuwei He, Ruhua Liu, Lingling Cui, Can Wang, Fang Wan, Ming Wang, Xinde Li, Hailong Li, Xinjiang Wu, Changgui Li
    Rheumatology 2020 59 10
  • The Ratio of ssDNA to dsDNA in Circulating Cell-Free DNA Extract is a Stable Indicator for Diagnosis of Gastric Cancer
    Xuewen Huang, Qi Zhao, Xianyuan An, Jie Pan, Lanjing Zhao, Lanfeng Shen, Yiqiu Xu, Dandan Yuan
    Pathology & Oncology Research 2020 26 4
  • Biosensor-Based Nanodiagnosis of Carcinoembryonic Antigen (CEA): an Approach to Classification and Precise Detection of Cancer Biomarker
    Maryam Hariri, Vahid Alivirdiloo, Nastaran Safavi Ardabili, Sarah Gholami, Sajjad Masoumi, Mohammad Reza Mehraban, Mahsa Alem, Reza Shah Hosseini, Ahmad Mobed, Farhood Ghazi, Iraj Alipourfard
    BioNanoScience 2024 14 1
  • Predictors of postoperative early recurrence of extrahepatic bile duct cancer
    Masayuki Akita, Tetsuo Ajiki, Kimihiko Ueno, Daisuke Tsugawa, Yu Hashimoto, Motofumi Tanaka, Masahiro Kido, Hirochika Toyama, Takumi Fukumoto
    Surgery Today 2020 50 4
  • The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients
    Xi-yu Liu
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022 Volume 15
  • <p>Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation</p>
    Yu-Cheng Cheng, Yu-Hsuan Li, Chiann-Yi Hsu, I-Te Lee
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020 Volume 13
  • Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus
    Mei Meng, Li-Li Shi
    World Journal of Diabetes 2024 15 2
  • Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study
    Zhaoyang Li, Jing Wang, Xu Han, Fei Wang, Hua Hu, Jing Yuan, Ping Yao, Sheng Wei, Huan Guo, Dan Zheng, Yuhan Tang, Handong Yang, Meian He
    Journal of Diabetes Investigation 2020 11 3
  • Correlation Between Blood Glucose Control and Levels of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Patients with Type-2 Diabetes Mellitus
    Dong Zhang
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022 Volume 15
  • Time–frequency analysis of serum with proton nuclear magnetic resonance for diagnosis of pancreatic cancer
    Asahi Sato, Toshihiko Masui, Akitada Yogo, Takashi Ito, Keiko Hirakawa, Yoshimasa Kanawaku, Kaoru Koike, Shinji Uemoto
    Scientific Reports 2020 10 1
  • Changes in serum tumor markers in type 2 diabetes mellitus with microalbuminuria
    Lina Chen, Shichun Du, Yan Bo Li, Qing Su, Jiangrong Zhang, Hongmei Zhang
    Frontiers in Endocrinology 2023 14
  • Serum carbohydrate antigen 72-4 concentrations decrease with age in females but not in males in Beijing, China
    Tongmei Duan, Xun Chen, Jing Wu, Ronghai Li, Huijuan Guo, Juan Du, Jie Guo
    Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2021 58 6
  • Sex-specific association between carbohydrate antigen 19–9 and incident type 2 diabetes
    Sujeong Shin, Yoosoo Chang, Seungho Ryu
    Scientific Reports 2024 14 1
  • Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study
    Pijun Yan, Jia Li, Yi Zhang, Xiaofang Dan, Xian Wu, Xing Zhang, Yuxia Yang, Xiping Chen, Shengxi Li, Pan Chen, Qin Wan, Yong Xu
    Diabetes, Metabolic Syndrome and Obesity 2024 Volume 17
  • Clinical significance of CA 72-4 as a serological tumor-associated marker
    N. S. Sergeeva, N. V. Marshutina, M. P. Solokhina, I. I. Alentov, A. D. Kaprin
    Onkologiya. Zhurnal imeni P.A.Gertsena 2019 8 2
  • Clinical significance of tumor markers in patients with type 2 diabetes: a retrospective observational study
    Maho Taguchi, Ryotaro Bouchi, Tatsuya Fukuda, Noriko Ihana-Sugiyama, Noriko Kodani, Mitsuru Ohsugi, Akiyo Tanabe, Kohjiro Ueki, Hiroshi Kajio
    Diabetology International 2023 14 1
  • Heavy black tea consumption and elevated CA 19-9 and CA 125 levels. A case report on a patient with ovarian endometriotic cysts
    Sophie Pils, Chiara Paternostro, Marius E. Mayerhoefer, Alexander Reinthaller, Michael Feichtinger
    Gynecological Endocrinology 2019 35 6
  • Pancreatic Cancer
    Xinzhe Zhu, Zhiwen Xiao, He Liu, Pin Zhang, Shengming Deng, Lei Ding, Jingjing Feng, Jianfeng Luo, Quanxing Ni, Guopei Luo, Xianjun Yu
    Annals of Surgery 2024 280 6
  • Tumor markers determination in malignant pleural effusion: pearls and pitfalls
    Wen-Qi Zheng, José M. Porcel, Zhi-De Hu
    Clinical Chemistry and Laboratory Medicine (CCLM) 2025 63 3
  • Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy
    Xiafei Zhao, Yan Wang, Ling Zhou, Aili Ye, Quanfeng Zhu
    Scientific Reports 2025 15 1
  • Comment on “Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report”
    Hiroshi Nomoto, Hideaki Miyoshi, Tomonori Sekizaki, Tatsuya Atsumi
    Annals of Thoracic and Cardiovascular Surgery 2018 24 3
  • Diabetic Ketoacidosis in Klinefelter Syndrome Sans Malignancy with Unusually Elevated Levels of CEA: A Case Report
    Xinxin Wo, Xiaoyan Yu, Lingling Miao, Yushan Mao, Keke Tang
    Diabetes, Metabolic Syndrome and Obesity 2025 Volume 18
  • Effect of glycotoxicity and lipotoxicity on carbohydrate antigen 19 − 9 in the patients with diabetes
    Xi-yu Liu, Xiao-hong Wang
    BMC Endocrine Disorders 2024 24 1
  • Elevated Serum Levels of Carbohydrate Antigen 72–4 in Diabetic Kidney Disease
    Lei Shi, Jiali Meng, Bin Zhang, Jiandong Chen, Jianzhong Chen, Jue Zhang
    Experimental and Clinical Endocrinology & Diabetes 2022 130 06
  • The Effect of Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic on the Metabolic Tumor Markers: A Real-World Retrospective Study
    Song Wen, Dongxiang Xu, Yue Yuan, Zhimin Xu, Yanyan Li, Min Gong, Xinlu Yuan, Ligang Zhou
    Diabetes, Metabolic Syndrome and Obesity 2024 Volume 17
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 38 (2)
Saudi Medical Journal
Vol. 38, Issue 2
1 Feb 2017
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control
Xiaojing Shang, Chunqing Song, Xiaoming Du, Hailin Shao, Donghong Xu, Xiaolai Wang
Saudi Medical Journal Feb 2017, 38 (2) 204-208; DOI: 10.15537/smj.2017.2.15649

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control
Xiaojing Shang, Chunqing Song, Xiaoming Du, Hailin Shao, Donghong Xu, Xiaolai Wang
Saudi Medical Journal Feb 2017, 38 (2) 204-208; DOI: 10.15537/smj.2017.2.15649
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Successful management of human parainfluenza virus-3 outbreak in a tertiary neonatal intensive care unit
  • Experience of pediatric liver disease at a university hospital in Western Saudi Arabia
  • Risk of malignancy in thyroid nodules Bethesda III sub classification into nuclear atypia and architectural atypia. A retrospective study
Show more Brief Communication

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire